Endotoxin accelerates atherosclerosis independent of complement activation.
Reifenberg
Kurt
K
Central Laboratory Animal Facility, Mainz. reifenbe@uni-mainz.de
Lehr
Hans-Anton
HA
Fan
Jianglin
J
Koike
Tomonari
T
Wiese
Elena
E
Küpper
Ines
I
Sagban
Tolga Atilla
TA
Schaefer
Stephan C
SC
Zähringer
Ulrich
U
Torzewski
Michael
M
Lackner
Karl J
KJ
Bhakdi
Sucharit
S
D000818:Animals; D050197:Atherosclerosis / Q000150:complications* / Q000473:pathology; D002097:C-Reactive Protein / Q000276:immunology; D002784:Cholesterol / Q000097:blood; D003167:Complement Activation; D003183:Complement C6 / Q000172:deficiency / Q000276:immunology; D004731:Endotoxins / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced; D008297:Male; D011817:Rabbits; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D003183:Complement C6; D004731:Endotoxins; D014280:Triglycerides; D002097:C-Reactive Protein; D002784:Cholesterol